Quantcast
Last updated on April 24, 2014 at 13:10 EDT

Latest Fludeoxyglucose Stories

2014-04-16 11:38:44

A functional brain imaging technique known as positron emission tomography (PET) is a promising tool for determining which severely brain damaged individuals in vegetative states have the potential to recover consciousness, according to new research published in The Lancet. It is the first time that researchers have tested the diagnostic accuracy of functional brain imaging techniques in clinical practice. "Our findings suggest that PET imaging can reveal cognitive processes that aren't...

2014-01-12 23:00:32

Mount Sinai Heart leads international research team testing new sugar-based tracer to help in the cardiovascular imaging hunt for inflamed high-risk, vulnerable artery plaques before they rupture. New York, NY (PRWEB) January 12, 2014 An international research team led by Mount Sinai Heart at Icahn School of Medicine at Mount Sinai is testing its novel sugar-based tracer contrast agent to be used with positron emission tomography (PET) imaging to help in the hunt for dangerous...

2013-10-04 10:12:02

Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of The Journal of Nuclear Medicine. Imaging with positron emission tomography/computed tomography (PET/CT) has shown that dense white blood cells in the outermost connective tissue in the vascular wall, increased C-reactive protein and a loss of smooth muscle cells in the middle layer of the vascular wall are...

2013-06-11 15:06:16

Parallel imaging improves risk stratification and patient management and hints toward potential benefits of simultaneous PET/MR For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging....

2013-06-11 14:53:38

Healthy test subjects with amyloid plaque were also found to have hypometabolism indicating a potential Alzheimer´s precursor Alzheimer´s disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer´s disease–even for people with no sign of cognitive decline. This is a new...

2013-06-11 13:59:05

Image correction and diagnostic capabilities of two hybrid molecular imaging systems found similar in a comparative heart imaging study Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR) imaging was found only in research institutes, but little by little the technology has expanded into clinical practice. This is especially true for cardiac indications, for which the highly sensitive soft tissue contrast of MR and the functional and metabolic...

2013-02-01 08:25:19

SAINT GENIS POUILLY, France, February 1, 2013 /PRNewswire/ -- Highlights - Acquisition of two well established radiopharmaceutical companies in Barcelona, Spain - Entry into Polish market following agreement with the University of Warsaw Advanced Accelerator Applications SA ("AAA"), a fast growing international player in Molecular Nuclear Medicine (MNM), today announced further expansion of its European radiopharmaceutical...

2012-08-07 02:29:31

LOS ANGELES and SINGAPORE, Aug. 7, 2012 /PRNewswire/ -- ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that it has signed a Master Service Agreement (MSA) with Singapore Radiopharmaceuticals Pte Ltd, a subsidiary of Fortis HealthCare. "This agreement represents an important component of our expansion program in Singapore as we establish R&D and pre-clinical imaging capabilities there," said Christian...

2012-07-11 02:26:18

CULVER CITY, Calif., July 11, 2012 /PRNewswire/ -- Sofie Biosciences, Inc., a molecular imaging company offering a comprehensive range of products from preclinical imaging systems to novel diagnostic PET imaging probes, announced today that the Department of Energy has awarded the company a grant under the Small Business Innovation Research (SBIR) program. This Phase II award, for approximately $1M, will support the development of a microscale technology for rapid, easy synthesis of PET...

2012-06-11 21:33:18

Study finds that the behavior of molecular imaging probes can indicate the effectiveness of a targeted therapy for patients with locally advanced rectal cancer A study presented at the Society of Nuclear Medicine's 2012 Annual Meeting reveals how molecular imaging biomarkers can be used to approximate howan experimental radiochemotherapy for locally advanced rectal cancer will work. Using already available imaging probes, scientists can assess the effectiveness before the course of...